title: Comment on Home et al. Insulin therapy in people with type 2 diabetes: opportunities and challenges? Diabetes care 2014;37:1499-1508.
authors.affiliation: Diabetes Unit, Endocrinology and Nutrition Department, University Hospital Clinic, Barcelona, Spain iconget@clinic.ub.es.
authors.forename: Ignacio
authors.initials: I
authors.lastname: Conget
authors.affiliation: LMC Diabetes & Endocrinology, Toronto, Ontario, Canada.
authors.forename: Ronnie
authors.initials: R
authors.lastname: Aronson
authors.affiliation: Medtronic Diabetes, Northridge, CA.
authors.forename: Scott
authors.initials: S
authors.lastname: Lee
authors.affiliation: Medtronic Diabetes, Northridge, CA.
authors.forename: Ohad
authors.initials: O
authors.lastname: Cohen
authors.affiliation: Department of Endocrinology, University of Caen Côte de Nacre Regional Hospital Center, Caen, France.
authors.forename: Yves
authors.initials: Y
authors.lastname: Reznik
mesh_terms: D001786:Blood Glucose / Q000378:metabolism*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use*
chemical_list: D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin